CRISPR Therapeutics AG (MEX:CRSP) Change In Other Working Capital : MXN35 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CRISPR Therapeutics AG Change In Other Working Capital?

CRISPR Therapeutics AG's Change In Other Working Capital for the quarter that ended in Mar. 2024 was MXN-32 Mil. It means CRISPR Therapeutics AG's Other Working Capital declined by MXN32 Mil from Dec. 2023 to Mar. 2024 .

CRISPR Therapeutics AG's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was MXN58 Mil. It means CRISPR Therapeutics AG's Other Working Capital increased by MXN58 Mil from Dec. 2022 to Dec. 2023 .

CRISPR Therapeutics AG Change In Other Working Capital Historical Data

The historical data trend for CRISPR Therapeutics AG's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRISPR Therapeutics AG Change In Other Working Capital Chart

CRISPR Therapeutics AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

-392.78

-190.96

70.12

249.12

58.44

CRISPR Therapeutics AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															-6.25	-24.26	112.14	-20.93	-31.57

CRISPR Therapeutics AG Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN35 Mil.

CRISPR Therapeutics AG Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of CRISPR Therapeutics AG's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CRISPR Therapeutics AG (MEX:CRSP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CRISPR Therapeutics AG (MEX:CRSP) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

CRSP:USA 0VRQ:UK

Address

Baarerstrasse 14, Zug, CHE, CH-6300

Website

https://www.crisprtx.com

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, exa-cel, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.